Canopy Growth Corp Research and Development Expense
Canopy Growth Corp (CGC) reported Research and Development Expense of CAD 2.61 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-06-15
- Canopy Growth Corp research and development expense for the quarter ending 2021-03-31 was 57.58M CAD.
- Canopy Growth Corp research and development expense for fiscal 2026 was 2.61M CAD, a 4.67% decline from fiscal 2025.
- Canopy Growth Corp research and development expense for fiscal 2025 was 2.74M CAD, a 40.53% decline from fiscal 2024.
- Canopy Growth Corp research and development expense for fiscal 2024 was 4.61M CAD, a 78.77% decline from fiscal 2023.
- Canopy Growth Corp research and development expense for fiscal 2023 was 21.72M CAD, a 32.68% decline from fiscal 2022.
| Period end | Research and Development Expense 3 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|
| 2026-03-31 | 2.61M CAD 10-K · filed 2026-06-15 | ||
| 2025-03-31 | 2.74M CAD 10-K · filed 2026-06-15 | ||
| 2024-03-31 | 4.61M CAD 10-K · filed 2026-06-15 | ||
| 2023-03-31 | 21.72M CAD 10-K · filed 2025-05-30 | ||
| 2022-03-31 | 32.26M CAD 10-K · filed 2024-05-30 | 32.34M CAD 10-K · filed 2022-05-31 | |
| 2021-03-31 | 57.58M CAD 10-K · filed 2023-06-22 | 57.58M CAD 10-K · filed 2022-05-31 | |
| 2020-03-31 | 61.81M CAD 10-K · filed 2022-05-31 | ||
| 2019-03-31 | 15.24M CAD 10-K · filed 2021-06-01 | ||
| 2018-03-31 | 2.05M CAD 10-K · filed 2020-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |